BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tosta E. The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal. Explor Immunol. [DOI: 10.37349/ei.2021.00014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Chikileva IO, Shubina IZ, Kiselevskiy MV. Modern antiviral biomedical cell products and their applications for COVID-19 therapy. Rossijskij bioterapevtičeskij žurnal 2022;21:19-32. [DOI: 10.17650/1726-9784-2022-21-2-19-32] [Reference Citation Analysis]
2 Kaewborisuth C, Wanitchang A, Koonpaew S, Srisutthisamphan K, Saenboonrueng J, Im-erbsin R, Inthawong M, Sunyakumthorn P, Thaweerattanasinp T, Tanwattana N, Jantraphakorn Y, Reed MC, Lugo-roman LA, Hunsawong T, Klungthong C, Jones AR, Fernandez S, Teeravechyan S, Lombardini ED, Jongkaewwattana A. Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice. Vaccines 2022;10:786. [DOI: 10.3390/vaccines10050786] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Chikileva I, Shubina I, Burtseva A, Kirgizov K, Stepanyan N, Varfolomeeva S, Kiselevskiy M. Antiviral Cell Products against COVID-19: Learning Lessons from Previous Research in Anti-Infective Cell-Based Agents. Biomedicines 2022;10:868. [DOI: 10.3390/biomedicines10040868] [Reference Citation Analysis]
4 Tosta E. The adaptation of SARS-CoV-2 to humans. Mem Inst Oswaldo Cruz 2022;116:e210127. [PMID: 35019068 DOI: 10.1590/0074-02760210127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]